Skip to main content

Table 4 Correlation between the relative ratios of studied cytokines and clinical parameters of obesity and type 2 diabetes mellitus

From: Adipose tissue-derived cytokines and their correlations with clinical characteristics in Vietnamese patients with type 2 diabetes mellitus

Clinical characteristics

Resistin/MCP-1

Resistin/RBP4

Visfatin/MCP-1

Visfatin/SFRP5

MCP-1/RBP4

Leptin/MCP-1

ρ (rho)

P value

ρ (rho)

P value

ρ (rho)

P value

ρ (rho)

P value

ρ (rho)

P value

ρ (rho)

P value

Fasting glucose (mmol/l)

0.01

0.88

− 0.47

< 0.0001

0.35

< 0.0001

0.1

0.29

0.51

< 0.0001

0.2

0.001

Triglycerides (mmol/l)

− 0.08

0.23

− 0.19

0.006

0.1

0.2

0.12

0.2

0.09

0.16

0.08

0.17

Total cholesterol (mmol/l)

− 0.07

0.3

− 0.02

0.8

− 0.03

0.7

− 0.09

0.32

0.05

0.48

0.12

0.55

HDL-C (mmol/l)

− 0.004

0.95

0.12

0.08

− 0.1

0.24

− 0.17

0.08

− 0.07

0.28

− 0.03

0.66

LDL-C (mmol/l)

0.008

0.9

0.06

0.4

− 0.02

0.78

− 0.22

0.019

0.01

0.8

0.13

0.035

Glycosylated hemoglobin (HbA1c) (%)

− 0.04

0.58

0.43

< 0.0001

0.23

0.004

0.03

0.7

0.44

< 0.0001

0.17

0.008

Insulin (mIU/l)

0.05

0.43

0.08

0.24

− 0.04

0.61

0.03

0.79

− 0.08

0.21

0.31

< 0.0001

HOMA-IR

0.04

0.59

− 0.17

0.014

0.14

0.084

0.083

0.39

0.19

0.003

0.35

<0.0001

QUICKI

− 0.05

0.44

0.17

0.014

− 0.16

0.055

− 0.08

0.41

− 0.21

0.002

− 0.35

<0.0001

HOMA-β

0.06

0.35

0.45

<0.0001

− 0.25

0.002

− 0.1

0.31

− 0.46

< 0.0001

0.02

0.72

  1. Relative ratios of resistin/MCP-1, resistin/RBP4, visfatin/MCP-1, visfatin/SFRP5, MCP-1/RBP4, leptin/MCP-1 were calculated and correlated with insulin levels, and HOMA-IR, QUICKI and HOMA-β indexes. The correlations were calculated by using Spearman’s rank correlation coefficient. Spearman’s rho (ρ) and P values are presented
  2. HOMA-IR Homeostasis Model Assessment-Insulin Resistance, QUICKI Quantitative Insulin Sensitivity Check Index, HOMA-β homeostatic model assessment-β-cell function, HDL-C high-density lipoprotein-cholesterol, LDL-C low-density lipoprotein-cholesterol